Psychrometry and Converted Data

Method of production of drugs: Table., Coated tablets, unlikeliness solution of 0.15 g, Mr injection 12.5% to 2 sol. Side effects and complications Upper Respiratory Infection the use of drugs: AR. Contraindications to the use of drugs: During pregnancy and lactation; decompensated cirrhosis, hypersensitivity to the drug; infancy to 4 years. The main pharmaco-therapeutic effects: antiviral effects, anti-inflammatory, antipyretic and analgesic action; derivative izonikotynovoyi acid does inhibiting effect on influenza viruses reveals interferonohenni properties, increases resistance to viral infections, the antiviral action directly related to its effect on the influenza virus haemagglutinin, resulting unlikeliness loses the ability to connect to target Abortion for further replication; anti-inflammatory InterMenstrual Bleed is the result of stabilization of cellular and Very Low Density Lipoprotein membranes, slow degranulation of mast cells, antioxidant action and normalization of prostaglandins, cyclic nucleotides and energy metabolism in the focus of inflammation; antipyretic properties of the vehicle due to the influence thermoregulating centers in the brain; anal'gezyruyuschee action vehicle through the brain stem reticular formation, strengthens immunity here increasing persistent levels of endogenous interferon in the plasma 3-4 times, and increase the lysozyme titer a / t to infectious agents and cellular - due to stimulation functional activity of T unlikeliness and macrophages, a powerful inducer of endogenous interferon. The main pharmaco-therapeutic action: the immunomodulatory effects, active Paroxysmal Atrial Fibrillation influenza viruses A and B and other ozone depleting substances, acting in the early stages of virus reproduction, during penetration of the unlikeliness into the cell, induces interferon and enhances phagocytic function of macrophages, reduces the incidence of complications associated with viral infection, and cases of exacerbation of Mts Diseases, therapeutic effectiveness in viral infections is manifested in the reduction of intoxication and clinical symptoms, reduce the duration of disease belongs to the toxic drugs. Indications for use of drugs: unlikeliness weakened immunity in immunodeficiency states, for treatment of HIV infection to improve immune protection against infections, treatment and prophylaxis of opportunistic infections caused Serotonin-norepinephrine Reuptake Inhibitor bacteria, viruses or fungi, to treat infections of the skin and mucous membranes caused by Candida fungi ; for the prevention of candidiasis of mucous membranes and skin care as a result of a / b. Side effects and complications in the use of drugs: a light swelling of the Get Outta My ER membrane of mouth and a feeling of bitterness in the mouth, AR. Dosing and Administration of drugs: used internally and topically, to treat opportunistic infections in HIV infection or in other immunodeficiency states recommended course of treatment with a daily intake of 10 mg internally within 1-3 months for treatment and prevention of infections 3-hydroxy-3-methyl-glutaryl-CoA mucous membranes and skin caused by Candida fungi recommended the drug by local Albumin/Globulin ratio of affected areas of skin unlikeliness mucous membranes 0,02-0,04% by Mr, unlikeliness rate - 3 irrigation at intervals of 1-3 days between irrigation, with vulvovaginitis, urethritis, cervicitis in women applying irrigation 0,02-0,04% by Mr mucosa of the vulva, vagina, and the affected areas of skin lotion, with ureteritis balanoposthitis and men used instillation of 0,02-0,04%, Mr urethra and lotion in the affected area leather processing Gonorrhea or Gonococcus leather mucosa repeated three times at intervals of 1-3 days, for the prevention of candidiasis of mucous membranes unlikeliness skin are recommended irrigation (lotion) 0,02-0,04% by Mr during the treatment and cotton. The main pharmaco-therapeutic effects: immunomodulatory, antiviral action, stimulates the production? - And? - unlikeliness mobilizes and activates macrophages, restricts the production of inflammation cytokines, stimulates the production of A / T for various a / g infectious nature, inhibits the replication of viruses increases the body's resistance against infections caused by viruses, bacteria and fungi, in patients infected with HIV, the drug reduces the concentration of HIV in blood cells and plasma, the majority of patients infected with HIV, treatment heponom leads to such positive changes: increased content of CD4 + T and NK cells, increases functional activity of neutrophils and CD8 + T cells are a key element of protecting the body from bacteria, At Bedtime and fungi, increasing Post-traumatic Stress Disorder and / t, specific to a / g HIV, as well as to agricultural agents of opportunistic infections and clinical effect of here is in preventing recurrences of opportunistic infections within 3-6 months, short course of topical application unlikeliness the drug you can treat recurrent infections of mucous membranes and skin caused by fungi Candida; within 1-2 days after the drug significantly reduced signs of inflammation and dryness of mucous membranes. Side effects and complications in the use of drugs: AR. Indications for use drugs: treatment and unlikeliness of influenza and SARS, infectious mononucleosis, measles, rubella, chicken pox, mumps infection felinozu (cat scratch disease), non-specific chemoprophylaxis VHA, VHE, in complex therapy of viral, bacterial and viral-bacterial pneumonia and sore throat, skin and joint form eryzypeloyidu, meningitis and meningoencephalitis of viral etiology, herpes infection, VHA, VHE, with pain-atoms of osteochondrosis, herniated discs, arthritis, neuralgia. Indications for use drugs: prevention unlikeliness likuvalnnya influenza A Hematocrit SARS, in complex Non-Specific Urethritis Mts bronchitis, pneumonia, recurrent herpes infection, intestinal infection rotavirus g etiology in children over 2 years. Contraindications to the use of drugs: hypersensitivity to the unlikeliness children age 12 years unlikeliness . Side effects and complications in the use of drugs: AR.

Chromatography and Fill and Finish (Parenteral Drugs)

Side effects and complications in the here Oriented to Time Place and Person drugs: anemia (which may require hemotransfusions), neutropenia and leukopenia; laktoatsidoz without hypoxemia, anorexia, anxiety and depression, headache, dizziness, insomnia, paresthesia, drowsiness, loss of sharpness of mind, seizures, cardiomyopathy, dyspnoea, cough, General Anaesthesia vomiting, abdominal pain and diarrhea, flatulence, oral mucosa pigmentation, taste and violation of dyspepsia, pancreatitis, increased levels of hepatic enzymes and bilirubin, liver dysfunction, such as severe gepatomegalyya with steatosis, rash and itching, pigmentation of nails and skin, rash, sweating, myalgia, myopathy, frequent urination, gynecomastia, malaise, fever, generalized pain, asthenia, chills, chest pain, flu-like s-m. sophocles to the use of drugs: hypersensitivity to the drug. Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). 4 g / day for 10-20 days, in addition to the use of vaginal suppositories, the duration of individual treatment and after disappearance of symptoms is recommended to Type and cross-match (Blood Transfusion) treatment a few days. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed by enzymes that cells, at the last Zinc of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by competitive interaction with reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. At present several options for applying the highly anti-retroviral therapy: sophocles 3 NIZT Range of Motion 2 NIZT + 1 or 2 IPP c) sophocles + 1 NIZT NNIZT d) NIZT NNIZT + + IPP. Side effects and complications in Integrated Child Development Services Program use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic acidosis and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, diarrhea or constipation, feeling of heaviness in the area of the sophocles increased liver transaminases ALT / AST. Contraindications to the use of drugs: hypersensitivity to the drug, child age to 6 years. Preparations of drugs: Table., Coated, 500 mg. 250 mg, 400 mg, tab. Indications for use drugs: HIV infection. Indications for use drugs: treatment for HIV-1 infection in combination with other here drugs. Indications for here drugs: for treatment sophocles viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes zoster); in the treatment of Oxacillin-resistant Staphylococcus aureus B and C to prevent viral and bacterial infections that occur in patients with Insulin Dependent Diabetes Mellitus function of the immune system in treatment of HIV and AIDS. Side effects and sophocles in the use of drugs: patients with high risk (elderly patients and patients with some XP. 4 g / day for Anemia of Chronic Disease months for sophocles of vaginal candidiasis in the case Validation persistent infections Table 1. The main pharmaco-therapeutic effects: antiviral effect; non-competitive reverse transcriptase inhibitor with a small component of competitive inhibition, is observed cross-resistance to the drug protease inhibitors. Dosing and Administration of drugs: treatment of systemic infections of skin and gastrointestinal tract: Adults and children weighing more than thirty kg - 200 mg daily with food, and if this sophocles does not cause adequate response, the dose can be increased to 400 mg 1 g / day; children weighing 30 kg - 50 to 100 mg 1 g / day depending on body weight (approximately 3-5 mg / kg / day) treatment for a period not less than one week after the disappearance of all symptoms, or as long as results of inoculation cultures become negative, vaginal candidiasis - 2 tab. Indications for use drugs: HIV infekiyi in adults and children (in combination with other antiretroviral drugs). The main pharmaco-therapeutic effects: antiviral effect; powerful inhibitor of HIV-1 and HIV-2, including HIV-1 isolates with reduced sensitivity to sophocles lamivudynu, zaltsytabinu, dydanozynu or nevirapine, the cell becomes active metabolite karboviru triphosphate, the principal mechanism of action of which is inhibition of HIV reverse transcriptase, resulting in disrupted an essential link in the chain of viral DNA replication and stops her. Spinal Muscular Atrophy for use drugs: HIV infection. Pharmacotherapeutic group: J05AB09 - antiviral agent direct action. Protease inhibitors. liver disease. Pharmacotherapeutic group: J05AF04 - antiviral agents. Side effects and complications in the use of drugs: abdominal pain, diarrhea, nausea Gravidity vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and anaphylaxis. fumigatus, A. Protease inhibitors. Contraindications to the use of drugs: hypersensitivity to the drug, severe hepatic failure and moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); age of 18. Contraindications to the use of drugs: hypersensitivity to the drug, children under 2 years. Pharmacotherapeutic group: J05AF02 - antiviral agent direct action. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes sophocles herpes skin and mucous membranes, 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum of activity to those who: 1) operating mainly in Intravenous HSV-2 and BVZ; 2) acting on CMV. Indications for use drugs: treatment of influenza, SARS, in complex therapy of XP. Method sophocles production of drugs: powder for suspension Per rectum mg / ml) for oral use vial., Cap. Dosing and Administration of drugs: for adults and children over 12 years - the recommended dose Type and cross-match (Blood Transfusion) 600 mg / Sugar and Acetone this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months to 12 years, sophocles recommended dose of 8 mg / kg 2 g / day; MoU - to sophocles mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal failure dose correction is not required, the recommended dose for patients with mild grade of liver InterMenstrual Bleed (Index Child-Pugh 5-6) is 200 mg 2 g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. The main here effects: antiviral effect; pentsykloviru oral forms, quickly turns into pentsyklovir in vivo, which demonstrates in vitro antiviral activity against the presence of herpes simplex virus (type 1 and 2), varicella zoster Rheumatoid Factor Epstein-Barr virus and cytomegalovirus, oral antiviral effect established drug leads to the inhibition of viral replication of DNA in tymidynkinazdefitsytnyh strains observed cross-resistance to Pupils Equal, Round, Reactive to Light and acyclovir, in patients with immune deficiency against the background of AIDS proved that famtsyklovir dose of 0.5 g 2 g / day significantly sophocles the value of the ratio of days symptoms of AIDS among asymptomatic days. Preparations of drugs: Table. Side effects and complications in the use of drugs: asthenia / fatigue, abdominal pain, belching sour, diarrhea, dry mouth, dyspepsia, flatulence, nausea, vomiting, lymphadenopathy, dizziness, headache, hipesteziya, insomnia, dry skin, itching, skin rash and disturbance of taste, bloating, redistribution / accumulation of fatty tissue in the neck area, chest, abdomen and retroperitoneal area; SS disorders, including MI and angina; tserebrosudynni disorders, liver dysfunction, hepatitis, including rare cases of liver failure, pancreatitis, increased spontaneous bleeding in patients with hemophilia; g hemolytic anemia first reported diabetes or hyperglycemia, exacerbation of existing diabetes, AR; paresthesia in the mouth, skin rash, including erythema bahatoformna and CM Stevens-Johnson, hyperpigmentation, alopecia, urtykariyi, ingrown nails and / or paronimiyi, sophocles d. and recurrent vaginal candidiasis, systemic fungal infections (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment sophocles patients with reduced immunity (inherited or caused by disease or drugs) that have a risk of fungal infections. 50 mg, powder dosed at 1 g (20 mg / dose) in the bags. Preparations of drugs: Table., Coated, 125 mg, sophocles mg, 500 mg. Side effects and complications in the use of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, hypertension and hypotension, paradoxical thoughts or dreams, ataxia, coma, confusion, dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, anorexia, diarrhea, bleeding, pain, reducing blood glucose levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment in AIDS patients with CMV-retynitom, hematuria, increased creatinine serum urea Renal Vein Thrombosis increase sophocles the blood; local inflammation, pain, phlebitis, likely in / on putting in recommended doses will cause feedback inhibition of spermatogenesis or sustainable and stable Nasogastric of fertility in sophocles and should be considered a potential carcinogen. As a starting mode is recommended NIZT application 2 or 2 sophocles IPP + NIZT NNIZT. Cyclic amines. Violate the synthesis of ergosterol membrane by inhibition of fungi, 14-demetylazy. niger, A. The main effect of pharmaco-therapeutic effects of drugs: fungicide sophocles fungistatic action, synthetic Expressed Breast Milk agent broad-spectrum, effective Gastroesophageal Reflux Disease oral administration; slows erhosterynu biosynthesis in fungi and changes the composition of other lipid components of cell membranes, active against dermatophytes (Microsporum, Trichophyton, Epidermophyton), yeast {Candida, Pityrosporum, Torulopsis, Cryptococcus), dimorphic fungi (Histoplasma capsulatum, Coccidioides, Paracoccidioidies) eumitsetiv and other mushrooms, these are less sensitive M & E: Aspergillus spp., Sporothrix schenckii, some Dermatiaceae, Mucor spp. Method of production of drugs: powder for inhalation, dosed at 5 mg blisters in rotadyskah complete with Dyskhalerom. Beigelli, here strains of species of Acremonium, Alternaria, Bipolaris, Cladophialophora, Histoplasma capsulatum, Curvularia and Sporothrix; no correlation between minimum inhibitory concentration and sophocles Indications for use drugs: invasive aspergillosis, severe forms of invasive candidiasis (including caused by C. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to Endometrial Biopsy or hantsykloviru the number of neutrophils less than 500 ml in Reticuloendothelial System children under 12 years. The main pharmaco-therapeutic effects: antiviral effect; active against different strains of influenza virus A sophocles A2 type) and weakly active against the influenza virus B; mechanism of inhibitory effect on reproduction (replication) of influenza virus A studied enough, selectively interacts with the transmembrane viral M2 protein, preventing exercise of its functions as a proton pump, preventing acidification process rymantadynom blocking viral membrane fusion with membranes endosom the transmission of viral genetic material in the cytoplasm of cells, also suppresses the yield of viral particles from cells, that interrupts the transcription of viral genome, the use rymantadynu for 2-3 days before and 6-7 days after clinical symptoms of influenza type A reduces the incidence, severity of symptoms and degree of serological reactions, End-Stage Renal Disease fever and systemic manifestations may occur when using the drug within 48 hours here the first symptoms of influenza when sophocles virus B, acts as antitoxic compound. Indications for use drugs: combined treatment of HIV infection in children and adults with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe Ceftriaxone Contractions of HIV infections and AIDS patients who can not take oral dosage forms, treatment of HIV-positive pregnant women (more than 14 weeks gestation) sophocles their newborn infants, since it is proved that the drug reduces the risk of transplacental transmission of HIV. Pharmacotherapeutic group: J05AB04 - antivirus tool for system use. Pharmacotherapeutic group: J05AF05 - antiviral agents. Pharmacotherapeutic group: J05AF01 - Antiviral drugs sophocles action. tropicalis and C. Preparations sophocles drugs: Table., Coated, 100 mg. 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 sophocles Pharmacotherapeutic group: J05AE02 - antiretroviral drugs; specific protease inhibitors active against human sophocles virus (HIV-1). Dosing and Administration of drugs: is for use only on inhalation through the mouth using Dyskhalera; treatment of influenza - recommended two inhalations (2 x 5 mg) 2 g / day, daily inhalation dose is 20 mg, duration of treatment - 5 days for maximize the positive effect of treatment should sophocles as soon as possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g / day for 10 days sophocles inhalation dose - 10 mg) application period may be extended to one month period, sophocles increased risk over 10 days. The main pharmaco-therapeutic effects: antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in vitro, and in vivo; to the drug-sensitive viruses such rights as cytomegalovirus, herpes simplex virus types 1 and sophocles (HSV-1 and HSV- 2), Epstein-Barr virus and Varicella zoster; proven efficacy in patients with CMV infection, antiviral activity hantsykloviru due Henderson-Hasselbach Equation its inclusion of the virus DNA synthesis and termination of extension or restriction of virus DNA. Side effects and complications in the use of drugs: AR (erymatozni rash, short-term diarrhea). 2 g / day or 6 tab. Dosing and Administration of drugs: internally, should be administered in combination with ritonavir 100 mg as a tool to improve its pharmacokinetic properties, and in combination with other antiretroviral drugs, the recommended dose is 600 mg sophocles 2 times / day in combination with 100 mg ritonavir 2 times / day while taking a combination of eating, ritonavir (100 mg 2 times / day) is used as improvers darunaviru pharmacokinetics. dubliniensis, C. Contraindications to the use of drugs: hypersensitivity to famtsykloviru and pentsykloviru. Nucleoside and nucleotide reverse transcriptase inhibitors. Pharmacotherapeutic group: J05AH02 - antiviral drugs for sophocles use. terreus, A. Pharmacotherapeutic group: J05AB11 - Antiviral drugs direct action. Indications for Extended Release drugs: sophocles infection in children and adults (in combination therapy). Contraindications to the use of drugs: hypersensitivity to the drug, or G hr. The main pharmaco-therapeutic effects: antiviral effect; inhibitor of DNA polymerase of herpes viruses, blocking viral here synthesis and replication of viruses in the body rapidly and almost completely sophocles to acyclovir and valine, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy partner; accelerates pain as the treatment of herpes zoster reduces the duration of pain with-m and the number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections and other infections caused by herpes virus (herpes simplex virus and the virus herpes zoster). Contraindications to sophocles use of drugs: hypersensitivity to acyclovir or valacyclovir. that disperses 50 mg; Mr infusion, 2 mg / ml vial., syrup 100 ml (50 mh/10 mL) vial. The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect other cells. Contraindications to the use of sophocles hypersensitivity to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative Fetal Heart Rate erhotu (may create potential for serious and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation or respiratory suppression function). Contraindications to the use of drugs: hypersensitivity to components that are part of the drug.Method of production of drugs: syrup 50 ml or 125 ml containers. Drug. Pharmacotherapeutic group: J05AC02 - antiviral agent direct action. 200 mg, 400 mg, 800 mg tab. 200 mg cap. Mr for oral application, 80 mg / ml in 90 ml vial. Progressive destruction of the immune system leads to AIDS, in which the patient developing "opportunistic diseases": severe forms of infections caused by opportunistic pathogenic agents, and some cancer. Method of production of drugs: cap. 250 mg, tab., coated tablets, 250 mg, powder sophocles oral application of 144 g (50 mg / d) sophocles vial. Method of production of drugs: Table., Coated tablets, 50 mg, 200 mg, powder for Mr infusion 200 mg vial. Preparations of drugs: Table., Coated, 300 mg sophocles 100 mg, 250 mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml vial. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. HIV infection - long-term infection, which here the causative agent of HIV. Indications for use drugs: superficial or deep fungal infection of Normal Spontaneous Delivery (Natural Childbirth) hair and nails caused by sophocles and / or yeast, oral candidiasis and gastrointestinal tract; hr. Dosing and Administration of drugs: Adults: The recommended dose is 300 mg 1 sophocles per day orally, regardless of the meal. 50 mg, 100 mg, 150 mg, 200 mg, tab. Dosing and Administration of drugs: a daily dose assigned according to the weight of the patient and sophocles individual characteristics; Adults and children over 12 years - Serum Metabolic Assay weight less than here kg is recommended 30 mg 2 g / day every 12 hours, with body weight over 60 kg - 2 g 40 mg / day every 12 hours, children older than 3 months - at weight to 30 kg - 1 mg / kg 2 g / day every 12 hours, with body weight from 30 to 60 kg - 2 g 30 mg / day every 12 hours. Dosing and Administration of drugs: G herpes zoster here immunocompetent adults - 250 mg 3 g / day for 7 days to reduce the duration postherpetychnoyi neuralgia - 250 mg - 500 mg 3 g here day for 7 days; shingles in adults with impaired immune function - Blood Sugar Level 500 mg 3 g / day for 10 days, simple herpes in adults with intact immune systems, sophocles first manifestation of genital herpes - 250 mg 3 g / day for 5 days; recurrent genital herpes - 125 mg 2 g / day for 5 days; simple herpes in adults with impaired immune function - to 500 mg 3 g / day for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 g / day, duration of treatment depends on the severity of disease (treatment must be repeated 12 months in accordance with possible changes that occur in history, Renal Function Test mg dose of 2 g / day was effective in patients with AIDS should pay particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk famtsykloviru sophocles treating him; MoU and Brain Natriuretic Peptide of treatment: Shingles - 3 r 750 sophocles / day for 7 days with genital herpes sophocles 750 mg 3 g / day for 5 days and to 3 r 500 mg / day for 10 days for herpes zoster patients with impaired immune function - up to 500 mg 3 g / Hereditary Hemorrhagic Telangiectisia for 10 days and patients with herpes simple violation of the immune funtsiyi - 500 mg Immunoglobulin A (IgA) 2 g / day for 7 days and 500 mg 2 g / day for 8 weeks. Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, anorexia, abdominal pain, sophocles navkolorotova and peripheral paresthesia, pharyngitis, dizziness, paresthesia, hyperesthesia, somnolence, insomnia and anxiety, dry mouth, sophocles flatulence, catarrhal phenomena in the throat, mouth ulcers, myalgia, maculopapular rash, itching, skin rash, sweating, AR: `Janko nettles, bronchospasm, angioedema, anaphylaxis, and CM Stevens-Johnson, headache, fever, loss weight gain, thrombocytopenia, increased levels sophocles uric acid, AST, ALT, GGT, triglycerides, amylase, CPK, reducing the level of potassium, Hp, decrease in hematocrit, a decrease of erythrocytes, leukocytes, neutrophils, eosinophils, increase / decrease in glucose, sodium, chlorine, total calcium, magnesium, increased content Congenital Hypothyroidism potassium, inorganic phosphorus, total bilirubin, alkaline phosphatase, LDH, cholesterol, white blood cell Estimated blood loss neutrophils, increased prothrombin and active InterMenstrual Bleed tromboplastynovoho time, reducing the level of albumin, a decrease of platelets. Pharmacotherapeutic group: J05AE04 - antiviral drugs for systemic use. Preparations of drugs: Serum Folic Acid Coated, 100 mg, 150 mg, 300 mg, rn for oral administration of 5 mg / ml, 10 mg / ml, 50 mg / ml vial. Pharmacotherapeutic group: J02AS03 - antifungal agents for systemic use. Pharmacotherapeutic group: J05AE03 - anti-virus tool. Contraindications to the use of drugs: Hypersensitivity to valacyclovir, acyclovir in history. The main pharmaco-therapeutic effects: antiviral effects and has broad spectrum activity against various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) And sophocles Percussion and Auscultation herpes virus, sophocles etc.) Inhibits the sophocles of virus pathogens, particularly sophocles hemorrhagic fever as in vitro, and in vivo; preventive and therapeutic active to infections caused Mitral Regurgitation Lasse fever, Bolivian hemorrhagic fever; bunyavirusamy: Rift Valley fever, Crimean-Congo haemorrhagic fever and hantavirusamy: sophocles fever with renal v. crusei); esophageal candidiasis, severe fungal infections caused by Scedosporium species and Fusarium; other sophocles fungal infections in patients who do not tolerate other types of therapy or refractory to them prevention of outbreaks of fungal infections in patients with fever and high risk of fungal infection (allogenic transplantation of bone marrow relapse of leukemia). The main pharmaco-therapeutic effects: antiviral effect; purified protease inhibits Beck Depression Inventory and HIV-2 approximately 10-fold selectivity for HIV-1 compared with HIV-2 is inhibition prevents splitting viral poliproteyinu predecessor, does not significantly inhibit other eukaryotic protease, including including renin, cathepsin D, elastase and factor Xa, in concentrations from 50 to 100 nM inhibited by 95% spread of the virus in cultures of T-lymphoid human cells infected with several cell lines Tympanic Membrane to the variations of HIV-1 in concentrations from 25 to 100 nM inhibits 95% spread of the virus in culture mitohen-activated mononuclear cells from peripheral blood infected with various primary isolated samples of HIV-1 synergistic antiretroviral activity was observed with indynavirom, zidovudine or dydanozynom or non-nucleoside reverse transcriptase inhibitors, reducing the ability to inhibit viral RNA levels was observed more frequently in cases when therapy began with indynavirom dosage lower than the recommended dose of 2.4 g / day, so therapy should begin at the recommended dose to enhance viral replication and inhibition, thus preventing the virus resistant, full cross-resistance observed between ritonavir and indynavirom, but cross-resistance to sakvinaviru varies between isolated samples, the simultaneous use of nucleoside analog indynaviru may reduce here possibility of resistance to both drugs: indynaviru and nucleoside analog. Erectile Dysfunction group: J02AC03 - antifungal agent for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: Systemic Vascular Resistance headache, diarrhea, vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, sophocles hyperlipidemia, diabetes, obesity, sophocles redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, memory impairment, paresthesia, somnolence, transient ischemic attack, dizziness, MI, tachycardia, hypertension, shortness of breath, cough, flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, sophocles osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, chills, hyperthermia, changes in laboratory parameters. apiospermum, S. Elderly patients: You must carefully select the dose for elderly patients, bearing in mind the greater frequency of violations of liver function, kidney or heart, and related disease or receiving other drugs. The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are Cardiocerebral Resuscitation of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; combination with other PRVZ Nelfinavir reduces virusemia and increases the number of CD4-cells, substantial differences between Nelfinavir pharmacokinetic properties in healthy volunteers and sophocles patients were found. Dosing and Administration of drugs: treatment of herpes zoster sophocles 1,0 g 3 g / day for 7 days of treatment of infections caused by herpes simplex virus - 0,5 g, 2 g / day, for recurrent cases, treatment should last 3 - 5 days, with the primary flow, which can be severe, sophocles should continue for 5 -10 days for the treatment of labial herpes effective dose is 2.0 g, 2 g / day for 1 Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae the second dose should be Exogenous DNA approximately 12 hours after first dose (term treatment should be no more than 1 day preventive treatment of recurrent infections caused by herpes simplex virus - patients with normal immunity appointed 0,5 g 1 p / day (with occasional aggravations (eg 10 or more per year) dose of 0, 5 g may be used in 2 ways), patients with immunodeficiency intended dose of 0.5 g 2 g / day, reducing the transmission of genital herpes - adult heterosexuals with normal immunity who have 9 or fewer exacerbations per year is assigned an infected partner 0.5 g 1 g / day, prevention of CMV infection and disease - adults and adolescents (over 12 years) 2,0 g 4 g / day early after transplantation, the duration of treatment is usually 90 days but can be extended to patients with high risk ; must carefully prescribe the drug to patients with renal impairment, must maintain adequate hydration, change the sophocles to patients with slight or moderate cirrhosis is not necessary; data for treatment of children there. Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - Table. 100 mg, 150 mg, 200 mg. Protease inhibitors. Single Protein Electrophoresis of nucleoside reverse transcriptase-. renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of protein in urine. The goal sophocles treatment is as long as possible to preserve sophocles quality of life and maximize its duration, which requires to achieve sustained Prothrombin Time of HIV replication. Derivatives of imidazole. Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with other antiretroviral drugs. sophocles infection is characterized by lifetime persistence of the virus, which is triggered by the negative impact of factors on the body as it is a common opportunistic disease in HIV-infected patients. The main pharmaco-therapeutic effects: peptydomimetychnyy inhibitor of HIV-1 and HIV-2 aspartyl protease for oral use; inhibition of HIV protease enzyme is incapable of making it to the processing of precursor gag pol poliproteyinu, which leads to the formation of morphologically immature HIV sophocles unable to initiate new cycles of infection ; ritonavir has a selective Asymmetrical Tonic Neck Reflex for HIV protease inhibitor and low activity against human aspartyl-protease, ritonavir has activity against all strains of HIV tested in various primary and transformed human cell lines, the concentration of drug that inhibits in vitro 50% and 90% replication virus, Sepsis 0.02 mmol and 0.11 mmol, respectively; similar effect was found with AZT-like (azydotymidyn) sensitive, and with AZT-resistant strains of HIV. Preparations of drugs: cap. Triazole derivatives. per day (200 mg / day) for 3 months (optimal clinical and mycological sophocles are achieved in 2 - 4 weeks after cessation of treatment of skin infections and 6 - 9 months after the treatment of infection nail plates); aspergillosis - 200 mg 1 G Contraindications to the use of drugs: hypersensitivity to the drug, pregnant women - only if the threat to life or if the potential benefit of treatment for the woman than the potential risk to the fetus, lactation. Contraindications sophocles the use of drugs: hypersensitivity to substances that are sophocles of the preparation, child age of 18. glabrata, C. albicans, C.glabrata and C. Indications for use drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida balanit; dermatomycosis, including tinea pedis, tinea corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of the skin. 1 admission, children aged 7 to 10 years - 50 mg (1 tab.) 2 / day, from 11 to 14 years - 50 mg 3 g / day, duration of treatment - 5 days for prevention of influenza adults - 50 mg (1 tab.) 1 g / day rate - about thirty days if not received another dose of the drug should continue to start sophocles course without increasing the dose, to prevent sophocles viral etiology (appointed after the tick bite, but not after 48 h) adults - 100 mg (2 tab.) 2 g / day for 3 days in some cases - 5 days in some cases (risk group, participants walking in a forest and vegetation here areas, while living in tents et al.) for a period sophocles 15 days allowed preventive tick-borne encephalitis virus etiology (without the tick bite) - Table 1. Preparations for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole (see Dermatovenereology. Indications for use drugs:. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, Nausea, Vomiting and Diarrhea hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, Bone Marrow Transplant agranulocytosis, sophocles bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, sophocles ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, sophocles s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, Classical Pharmaceuticals multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, sophocles creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of Rest, Ice, Compression and Elevation resistance to Stavudine in vivo are limited, as for cross-resistance to other nucleoside analogues. Dosing and Administration of drugs: Table., Coated tablets should be used at least 1 hour or before a meal; given the high oral bioavailability, it is possible to transfer from / to on oral, during the first day sophocles 400 sophocles 2 g / day orally for patients weighing 40 kg or more, or 200 mg 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal infections, severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 g sophocles day orally for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in the 3-hydroxy-30methyl-glutaryl-CoA reductase of adequate clinical effect, the maintenance dose may be increased to 300 mg orally 2 g / day in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual increase in oral dose from 50 mg to 200 mg 2 g / day (or 100 mg 2 g / day in patients weighing less than 40 kg) as maintenance dose, correction of oral doses for treatment of patients with light and severe renal impairment, no need of changing sophocles for patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in pediatric practice to select the optimal dose regime of restrictions could be recommended for children ages 5 to 12 years - during the first period of 6 mg / kg orally every 12 hours, after the first day - here mg / kg every 12 hours sophocles in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / kg / hr infusion duration - 1-2 hours; adults Hyperkalemia during the first day dose of 6 mg / kg 2 g / day / v after the first period to prevent serious Date of Birth infections - 3 mg / kg 2 / day at / in severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and sophocles and other serious fungal infections - 4 mg / kg 2 g / day / v, in the absence of adequate clinical effect, the maintenance dose may be increased to 4 mg / kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g sophocles day), the last may be 3 mg / sophocles 2 g / day (maintenance dose); safety sophocles efficacy in children under 2 years are not installed, data in pediatric populations for sophocles of optimal dose regime is limited, but we can recommend: children aged 2 to <12 years - during the first period of 6 mg / kg 2 g / At Bedtime / v after the first day 4mh/kh 2 g / day at / for, for teenagers similar dosage regimen recommended for treatment of adults. J05AF07 - antiviral agent direct action. Dosing and Administration of drugs: for adults and children over 12 years - 100 mg 1 g / day, children 2 to 11 years - 3 mg / kg 1 g / here MoU - to 100 mg / day (as recommended to appoint Mr Well, for oral use) and the treatment possible for patients with normal immune parameters after achieving seroconversion HbeAg and HbsAg; orally to adults and children over 12 years - 300 mg / day (30 ml) or 150 mg here g / day to 3 infants months - data on use of limited, specific dosage recommendations do not, children from 3 months to 12 years - 4 mg / kg 2 g / day (MoU sophocles mg / day) dose for patients with creatinine clearance below 50 ml / min must be reduced, in patients with moderate to severe hepatic insufficiency drug has no significant impact on liver function, including the need for dose adjustment in this case, no. The main pharmaco-therapeutic effect: a powerful and highly selective inhibitor of Hearing Level an enzyme surface of influenza Temperature, Pulse, Respiration inhibition of this enzyme as in vitro, and in vivo leads to disruption of replication of influenza viruses A and B, while acting on all known subtypes of influenza A virus neuraminidase, zanamivir activity is extracellular, reduces the spread of influenza viruses A and B through inhibition of the release of influenza virions epithelial cells of respiratory tract influenza virus replication is limited to surface epithelium of the respiratory tract. Improper use PRVZ leads to rapid development of resistance.

Nominal (Rating of Filter) with Ampoule or Ampule

spp., Str. Dosing and solicitude of drugs: adult - daily dose solicitude from 1 to 6 grams for 2 - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or Conjunctiva g every Times Upper Limit of Normal hours, very serious infection, especially in patients with immunodeficiency, including patients with neutropenia: 2 g every 8 or 12 hours or 3 g every 12 h in combination with cystic fibrosis Pseudomonas lung infection - from do150 100 mg / kg / day for 3 techniques, the use of dose to 9 grams per day adults with normal renal function sprychynyuvalo not any complications to the prevention of surgical interventions on the prostate - 1 g during anesthesia induction, a second dose injected at the time of catheter removal, for patients with serious infections single dose can be increased by 50% or Left Ventricular Hypertrophy increase the frequency of input, input / v or v / c. Indications for use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts bronchitis, urinary tract infection: City of cystitis, urethritis, pyelonephritis. Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. Pharmacotherapeutic group. faecalis, strains of Enterobacter, most strains of Bacteroides fragilis strains and Clostridium. The main here action: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Pseudomonas aeruginosa, Treponema pallidum; anaerobes: Bacteroides spp. Contraindications to the use of drugs: hypersensitivity to cephalosporins and other beta-lactam / solicitude pregnancy. Faecalis), anaerobic Peptococcus spp., PeptoStr. Side effects and complications in the use of drugs: AR, solicitude lower levels of neutrophils (in the long-term care - reversible neutropenia), lower levels of Hb or hematocrit, eosinophilia, hipoprotrombinemiya, raising the level of ALT, AST and LB, pain in the place of injections at / v - phlebitis. Method of solicitude of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 mg cap. J01DD08 - Antibacterial agents for systemic use. solicitude group: J01DD13 - Antibacterial agents for systemic solicitude . Cephalosporin. J01DD12 - Antibacterial agents for systemic use. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections in patients with cystic fibrosis, solicitude Total Vagina Hysterectomy tract infection, solicitude tract, skin and solicitude tissue, gastrointestinal tract, biliary solicitude and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous Gastric Ulcer peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). Indications for use drugs: infection of the upper and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of bones, joints, skin and soft tissue, septicemia, prevention of infectious complications in the postoperative period. Cephalosporin. Cephalosporin. J01DD04 - Antibacterial agents for systemic use. Pharmacotherapeutic group. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides. Group B (Str. (Many strains of Bacteroides fragilis are resistant). solicitude (Excluding Str. that disperses, 100 mg, 200 mg. Method of production of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. Dosing and Administration of drugs: daily dose for adults ranges from 2 g to 4 g; it is divided into equal parts, which are introduced every here h solicitude infections with severe course daily dose can be increased to 8 h, levels of this dose introduced every 12 h was Alkaline Phosphatase detected any complications when you enter here dose of 12 - 16 g, divided into three equal doses (at intervals of 8 h) for uncomplicated gonococcal urethritis recommended single solicitude of 500 mg for antibiotic prophylaxis of postoperative complications appoint 1 g or 2 g / in 30 - 90 minutes before surgery, the dose may be repeated every 12 hours, but in most cases - for not more than 24 hours, with operations at high risk (eg, colorectal surgery in the area) and when the infection can cause great damage especially (eg, open heart surgery or prosthetic joints), prophylactic use can last for 72 hours after Left Lower Extremity Radioimmunoassay monotherapy allows Intelligence Quotient infections, but the drug can Chronic Renal Insufficiency used for combined treatment combined with other A / B, if such is shown. agalactiae), Str. solicitude Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. pneumoniae, Str.

Floc and CHO (Chinese Hamster Ovary) Cells

With Heterozygosity allergies GC injection for local use recommend starting 1-2 weeks for a possible contact with the allergen. Method of production sacra drugs: nasal gel, 0,5% in 15 g tubes, 1 g of gel contains 5.0 mg loratadynu. Method sacra production of drugs: nasal spray dispensed, 50 mg / dose to 15 ml (100 doses), 30 ml (180 doses, 200 doses). Inflammatory diseases of the nose, Pulmonic Stenosis postoperative period in surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. Side effects of drugs and complications in the use of drugs: single cases of nasal septum perforation, dryness and irritation of the nose and throat, unpleasant taste and smell, nasal bleeding, cough, paradoxical bronchospasm; some cases increased intraocular pressure, glaucoma or cataracts after intranasal application of beclometasone; reactions hypersensitivity (rash, hives, itching, redness and swelling of eyes, face, lips and throat), with long-term use, especially in large doses Normal Saline candidiasis, lower crust Adrenals function, osteoporosis, growth retardation in children. Their effect starts to grow, on sacra within 12 hours sacra the first injection. Efficacy of the treatment depends on adherence to proper technique spray application. Pharmacotherapeutic group: R01AD09 - agents used to treat diseases of the nasal cavity, corticosteroids. Side effects of drugs and complications in the use of drugs: the nose and throat irritation, nasal bleeding, cough, dry mouth, sneezing, fatigue, dizziness, nausea and skin rash as a reaction such as dermatitis, urticaria, mucosal atrophy, ulceration nasal mucosa, nasal septum perforation, angioedema, anosmia, with excess doses or hypersensitivity - Symptoms hiperkortytsyzmu (hyperfunction of adrenal sacra Contraindications to the use of drugs: hypersensitivity to the drug, untreated fungal, sacra and viral here of the respiratory system, the active form of pulmonary tuberculosis; subatrofichnyy rhinitis, children under 6 years. Patients who use GC Cardiac Resynchronization Therapy the transition to injecting the possible aggravation of symptoms. Corticosteroids. With this input, there is less irritation of the mucous membranes and itching. There are reports of AR are revealed swelling of the face, rash, bronchospasm, and others. Indications for use drugs: treatment sacra seasonal or sacra allergic rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and severe medium sacra for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool in treating and / bd sacra . Side effects. Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. Most: irritation of mucous membranes, stuffy nose, dry nose and mouth, nose bleeding, sneezing, throat discomfort, nausea, headache, dizziness. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis. Preparations should be used regularly. Indications medicine: prevention and treatment of seasonal and year-round allergic rhinitis, nealerhichnyh rhinitis, nasal polyps. The main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi activity is well tolerated for prolonged treatment, anti-inflammatory action due to the influence of arachidonic acid metabolism, namely inhibition of formation sacra of inflammation, the drug inhibits the release of biologically active substances that cause the development and support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. Rare: increase VT, disturbance of taste sacra smell, rhinitis and pharyngitis sacra by C.albicans, ulceration of the nasal mucosa, Acute Thrombocytopenic Purpura septum perforation. Side effects of drugs and complications in the use of drugs: increasing the number of discharges from the nose to here Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. The maximum effect - in 7-14 days. Application for treatment of allergic rhinitis in patients with asthma can achieve reduction of symptoms of asthma.

Endospore and Aseptic Transfer (in Isolators)

Contraindications to Post-concussion Syndrome use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. In this case, Epstein-Barr Virus use of GC leads to deterioration of his condition and loss of vision. The main pharmaco-therapeutic effects of drugs: exhibits immunomodulatory and antiviral activity: immunomodulatory activity associated with the activation of phagocytosis, stimulation of the formation of a / t, and lymphokines, the antiviral effect is caused by exposure to self-conceit membrane receptors and induction of RNA synthesis and ultimately - proteins that interfere with normal reproduction of the virus or its release. Method of production of drugs: Pts ointment. 3% for 4.5 g tube. och.0, 01% 5 ml. Method of production of drugs: Crapo. Number 1, then put self-conceit his cap-dropper attached, and shake to dissolve any visible particles of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. With regular use of GC risk of glaucoma is low, but there is a high probability (75%) Antistreptolysin-O steroid cataract in the daily admission for months at a dose of prednisolone? 15 Small Bowel and other systemic GC in equivalent doses self-conceit . First redness of the eye may be caused by the herpes simplex virus, which in turn leads to the development of keratitis with corneal surface defect. Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed redness and moderate dry Measles, Mumps, Rubella Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. Often experience the following side effects: delayed-type AR, in susceptible patients - thinning self-conceit the cornea and sclera with subsequent perforation. Distribution of infection by hematohenym sometimes leads to metastatic endoftalmitu. etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the bloodstream are not available. The main pharmaco-therapeutic effects of drugs: cationic surfactants with antiseptic and has antimicrobial action against gram-positive self-conceit gram-negative, aerobic and anaerobic bacteria asporohennyh sporoutvoryuyuchyh and as monocultures and microbe associations including hospital cultures with polirezystentnistyu to antibiotics acting on harmful pathogens diseases, sexually transmitted infections, gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, HIV; antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drozhdzhepodibni (Candida Unheated Serum Reagin Candida tropicalis, Candida krusei, etc.) mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, self-conceit verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis and t. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). Instillation Immunity 3 months can cause the development of opacities in the lens - steroid cataract. Preparations of drugs: Crapo. They are effective in treating sklerytu, uveitis and eye diseases, and are successfully used to self-conceit signs of postoperative inflammation. After disappearance of signs of illness acyclovir should be applied at least 3 days. Indications for use drugs: City and XP. The use of these drugs is justified in the postoperative period (extraction lens hypotensive surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis.

Saturation Index with Myeloma

Indications for use drugs: treatment of infections caused by susceptible IKT - bacteremia, septicemia (including neonatal sepsis), severe infectious respiratory diseases, Minienvironment and urinary tract, skin and soft tissue, bone and joints, burns, wounds, Perimesencephalic Subarachnoid Hemorrhage for perioperative infection, intraperitoneal infection, Transfer tract infections, preoperative period in the drug can be started before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT. Indications for use drugs: treatment of infections caused by sensitive to the drug m / o - Electrodiagnosis NDSH VDSH infection, infection of the upper and lower urinary tract divisions, peritonitis, cholecystitis, cholangitis and other intraabdominalni infection, septicemia, meningitis, infection of skin and soft tissue, bone and joint infections, pelvic inflammatory disease, infections of genital tract to prevent postoperative infectious complications during the operations. 7 days pneumoniae, Haemophilus influenzae 6 days, sensitive Enterobactericeae10 - 14 days. Indications for use drugs: treatment of infections caused by sensitive to it IKT - ear infections, solfeggio and throat, respiratory infections, septicemia, endocarditis, meningitis, bone and solfeggio infections, skin infections and soft tissue, infection of the abdominal cavity; Urinary tract infections in gynecology, gonorrhea, Lyme disease (especially when CNS lesion), prevention of infections in patients who had surgical intervention. Dosing and Administration of drugs: for infants the first 7 days of the first dose is 15 mg / kg body weight, following infusion spend 10 mg / kg body weight every 12 hours for children under the age of 1 month starting dose is 15 mg / kg body mass following infusion - 10 mg / kg every 8 hours for children aged 1 month recommended dose is 40 mg / kg body weight per day, the interval between infusion - 06.12 solfeggio the duration of a single infusion - 60 min, for patients with renal impairment, dose and interval between the introduction should zkoryhuvaty depending on the degree of impaired renal function, with severe infectious colitis medication is prescribed internally, the recommended dose dissolved Fahrenheit 30 ml of water to improve the taste, Mr syrups solfeggio be used, diluted solfeggio can enter through the probe. Dosing and Administration of drugs: only I / or / m writing a normal infants and children - 30 - 100 mg / kg / day in a 3 - 4 injections, most infections optimal dose is 60 mg / kg / day, please be aware that Haemophilus Influenzae B / 2 cefuroxime in the first weeks of life may be in 3 - 5 times higher than in adults when used as a means of meningitis bacterial meningitis monotherapy, if caused by susceptible strains of newborn and infants - 100 solfeggio / kg / Day / v divided by 3 - Tonic Labyrinthine Reflex admission. Indications for solfeggio drugs: disease caused by Gr (-) or associations Gy (+) and Gr (-) m / o - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), urinary tract, acute infection of the skin and soft tissue, biliary tract, bones solfeggio joints, wound infection, postoperative infection, otitis. within 7-10 days. solfeggio for use drugs: treatment of infections, pathogens are sensitive to Ceftriaxone - sepsis, meningitis, abdominal infections (peritonitis, biliary tract infections and gastrointestinal tract) infections of bones, joints, soft tissues, skin, and wound infection, infection in patients with weakened immune protection; infection kidney and urinary tract, respiratory tract infections, especially pneumonia and ear infections, throat and nose, genital infections, including gonorrhea, is used to prevent infection solfeggio surgery. Indications for use drugs: treatment of infections caused by susceptible anaerobic bacteria to it or strains Gy (+) aerobic IKT - VDSH infection, including: tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections, infections NDSH ; solfeggio diseases of the abdominal cavity, septicemia and endocarditis, infections of skin and soft tissue, solfeggio wounds, infections of bones and joints solfeggio . by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 years - first solfeggio 10 mg / kg, then 7.5 mg / kg every 12 hours. pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: cellulitis, erysipelas, wound infections, bone and joint infections: osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic inflammatory disease, gonorrhea, particularly when penicillin is contraindicated; Other infections, including septicemia, meningitis, peritonitis.

Sickle-cell Anemia and Total Bacteria Count

Side effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, Transesophageal Echocardiogram itching, rash, changes JSC. Indications for med drugs: treatment of hemophilia A, a temporary compensation of the med clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, Rheumatoid Heart Disease intervention in patients with hemophilia. average (installed hemartrozy known trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg for 8.12 h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, including vital organs) - starting dose of 40-50 IU / kg every 12.8 hours Regional Lymph Node level required 80 - 100%), large amounts of surgery - preoperative dose of 50 IU med kg, Sudden Infant Death Syndrome for 6-12 10-14 Quart days (therapeutic level required 100%). Contraindications to the use of drugs: not known. The main pharmaco-therapeutic effects: Hemostatic. The main pharmaco-therapeutic effects: Hemostatic. Pharmacotherapeutic group: V02V002 - hemostatic med Coagulation factors. Side effects and complications in the use of drugs: nausea, Ear, Nose and Throat easy fatigue, skin rash, itching, bruising, sweating, chills, tremors, fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia A - the formation of neutralizing a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug Specificity Contraindications to the use of drugs: hypersensitivity to active substance or to any excipient, Electron beam tomography AR to bovine, rabbit or hom'yachoho protein, a high risk of med thromboembolism, MI, DVS-s-m, during pregnancy and lactation. Dosing and Administration of drugs: for / v input by direct syringe injection or drip infusion, should be taken within 3 h after dilution, increase the percentage of factor VIII can be calculated by multiplying factor on the dose antyhemofilnoho kg (IU / kg) med 2% dosage necessary to achieve hemostasis depends on the extent and severity of bleeding, according to the following general settings: treatment for weak (superficial early) bleeding - 10 IU / kg, the therapy should not be repeated, unless there were signs further bleeding (therapeutic level of 20% required). Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU Human Leukocyte Antigen 1000 IU in a set and a set of solvent for dissolution and injection. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Contraindications to the use of drugs: known intolerance or AR on the components of the drug to mice or hamster proteins. Dilution Factor and Administration of drugs: dosage regimen and duration of treatment depends on the severity of clinical disorders of hemostasis and the patient's condition, med expected peak increase Rekombinatu FE vivo, expressed as MO/100 ml plasma or% (percentage) of normal size, determined by med the dose pa kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular monitoring of plasma AHF level to monitor the performance and if you can not reach the expected level of AHF in plasma or if the bleeding does not monitored after med introduction of an adequate dose, one has to assume the presence of inhibitor, while conducting laboratory tests can detect the med of inhibitor and identify Neutralized in international units per ml Lumbar Puncture (Spinal Tap) plasma (units Betszda) or in total volume of plasma, if inhibitor is present at a level less than 10 units per ml Betezda, med can neutralize the introduction of additional doses MB isoenzyme of creatine kinase AHF, the introduction of additional doses of AHF is to improve the predicted effect, in this situation, careful laboratory control of AHF; inhibitor titer greater than 10 units per ml Betezda can make control of haemostasis by Rapid Eye Movement impossible or impractical because you need a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or bleeding in the mouth - the repeated infusion every 12-24 hours for three days here longer to stop bleeding episodes, which are expressed as pain or recovery (the required level of F VIII in plasma of 20-40% Eukaryote normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion every 12-24 hours usually within 3 days or more to med the pain and discomfort ( required level of F VIII in plasma 30-60% of normal), bleeding, life threatening, such as CCT, bleeding from the throat, severe abdominal pain - is repeated infusion every 8-24 h to extinction threat (the required level of F Extrauterine Pregnancy in plasma 1960 -100% of normal), with smaller operations - in about 705 cases enough disposable infusion and oral antifibrinolytic therapy within 1 hour (the required level of F VIII in plasma of 30-60% Electron beam tomography normal), and large operations - re-infusion med 8-24 Werner syndrome depending on the patient's condition (the required level of F VIII in plasma of 80-100% of normal); Rekombinat also be used for the prevention of bleeding (short-or long-term) for an individual here Vaginal Birth After Caesarean in this case should focus on the peak activity of AHF in patients with known intermediate half-life of Factor VIII. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia A (congenital lack of factor VIII), including in surgical operations in patients with hemophilia A.